These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 35069909)

  • 1. Decreased E2F2 Expression Correlates with Poor Prognosis and Immune Infiltrates in Patients with Colorectal Cancer.
    Shang Y; Zhang Y; Liu J; Chen L; Yang X; Zhu Z; Li D; Deng Y; Zhou Z; Lu B; Fu CG
    J Cancer; 2022; 13(2):653-668. PubMed ID: 35069909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal cancer with low SLC35A3 is associated with immune infiltrates and poor prognosis.
    Lu S; Sun X; Tang H; Yu J; Wang B; Xiao R; Qu J; Sun F; Deng Z; Li C; Yang P; Yang Z; Rao B
    Sci Rep; 2024 Jan; 14(1):329. PubMed ID: 38172565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased E2F2 predicts poor prognosis in patients with HCC based on TCGA data.
    Zeng Z; Cao Z; Tang Y
    BMC Cancer; 2020 Oct; 20(1):1037. PubMed ID: 33115417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SLC2A1 is a Diagnostic Biomarker Involved in Immune Infiltration of Colorectal Cancer and Associated With m6A Modification and ceRNA.
    Liu XS; Yang JW; Zeng J; Chen XQ; Gao Y; Kui XY; Liu XY; Zhang Y; Zhang YH; Pei ZJ
    Front Cell Dev Biol; 2022; 10():853596. PubMed ID: 35399515
    [No Abstract]   [Full Text] [Related]  

  • 5. SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer.
    Li T; Yan Z; Wang W; Zhang R; Gan W; Lv S; Zeng Z; Hou Y; Yang M
    Front Mol Biosci; 2021; 8():687319. PubMed ID: 34938771
    [No Abstract]   [Full Text] [Related]  

  • 6. INHBB Is a Novel Prognostic Biomarker Associated with Cancer-Promoting Pathways in Colorectal Cancer.
    Yuan J; Xie A; Cao Q; Li X; Chen J
    Biomed Res Int; 2020; 2020():6909672. PubMed ID: 33083477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor microenvironment-related gene selenium-binding protein 1 (SELENBP1) is associated with immunotherapy efficacy and survival in colorectal cancer.
    Zhu C; Wang S; Du Y; Dai Y; Huai Q; Li X; Du Y; Dai H; Yuan W; Yin S; Wang H
    BMC Gastroenterol; 2022 Oct; 22(1):437. PubMed ID: 36253721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCDC68 predicts poor prognosis in patients with colorectal cancer: a study based on TCGA data.
    Zhang W; Xu TT; An ZT; Wei LF; Gu C; Li H; Tian YZ
    J Gastrointest Oncol; 2022 Apr; 13(2):657-671. PubMed ID: 35557589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MTUS1 is a promising diagnostic and prognostic biomarker for colorectal cancer.
    Cheng LY; Huang MS; Zhong HG; Ru HM; Mo SS; Wei CY; Su ZJ; Mo XW; Yan LH; Tang WZ
    World J Surg Oncol; 2022 Aug; 20(1):257. PubMed ID: 35962436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma.
    Ma C; Kang W; Yu L; Yang Z; Ding T
    Front Oncol; 2020; 10():590006. PubMed ID: 33363020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic Analysis of E2F Expression and Its Relation in Colorectal Cancer Prognosis.
    Xu Z; Qu H; Ren Y; Gong Z; Ri HJ; Zhang F; Shao S; Chen X; Chen X
    Int J Gen Med; 2022; 15():4849-4870. PubMed ID: 35585998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Grid2 interacting protein is a potential biomarker related to immune infiltration in colorectal cancer.
    Zhao J; Quan J; Chen W; Xie X
    Eur J Med Res; 2023 Nov; 28(1):511. PubMed ID: 37964339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NDUFA4L2 is a novel biomarker for colorectal cancer through bioinformatics analysis.
    Lin Y; Xie H; Zhao W; Li Y; Zhang Z
    Medicine (Baltimore); 2023 Nov; 102(44):e35893. PubMed ID: 37933010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BICDL1 Predicts Poor Prognosis and is Correlated with Methylation and Immune Infiltration in Colorectal Cancer.
    Luo H; Luo J; Ding N; Zhang T; He Y
    Pharmgenomics Pers Med; 2023; 16():1109-1126. PubMed ID: 38149287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapk14 is a Prognostic Biomarker and Correlates with the Clinicopathological Features and Immune Infiltration of Colorectal Cancer.
    Wang D; Peng L; Hua L; Li J; Liu Y; Zhou Y
    Front Cell Dev Biol; 2022; 10():817800. PubMed ID: 35141222
    [No Abstract]   [Full Text] [Related]  

  • 16. Abnormal expression of ABCD3 is an independent prognostic factor for colorectal cancer.
    Zhang Y; Zhang Y; Wang J; Yang J; Yang G
    Oncol Lett; 2020 May; 19(5):3567-3577. PubMed ID: 32269631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. USP20 is a predictor of poor prognosis in colorectal cancer and associated with lymph node metastasis, immune infiltration and chemotherapy resistance.
    Jin R; Luo Z; Jun-Li ; Tao Q; Wang P; Cai X; Jiang L; Zeng C; Chen Y
    Front Oncol; 2023; 13():1023292. PubMed ID: 36874086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RBM39 is a potential prognostic biomarker with functional significance in hepatocellular carcinoma.
    Cui F; Wang W; Zhuang C; He D; Wang P
    Transl Cancer Res; 2024 Apr; 13(4):1606-1622. PubMed ID: 38737697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phospholipase A/acyltransferase 4 is a prognostic biomarker and correlated with immune infiltrates in pancreatic cancer.
    Li TH; Wang YY; Zhao BB; Qin C; Li ZR; Wang WB
    Heliyon; 2022 Sep; 8(9):e10416. PubMed ID: 36091946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
    Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
    BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.